Literature DB >> 1385776

Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor.

M Zamanian1, N B La Thangue.   

Abstract

The retinoblastoma (Rb) gene product forms a complex with the cellular transcription factor DRTF1, a property assumed to be important for mediating negative growth control because certain viral oncogenes, such as adenovirus E1a, prevent this interaction and mutant Rb alleles, which have lost the capacity to regulate growth, encode proteins that fail to associate with DRTF1. In this study, we show that the wild-type Rb protein can specifically repress transcription from promoters driven by DRTF1 whereas a naturally occurring mutant Rb protein cannot. Furthermore, Rb-mediated transcriptional repression can be overridden by adenovirus E1a; this requires regions in E1a necessary for cellular transformation. The Rb protein therefore acts in trans to repress the transcriptional activity of DRTF1 whereas adenovirus E1a prevents this interaction and thus maintains DRTF1 in a constitutively active state. The Rb protein and adenovirus E1a therefore have opposite effects on the activity of a common molecular target. Transcriptional repression mediated by the Rb protein and inactivation of repression by the E1a protein are likely to play an important role in mediating their biological effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385776      PMCID: PMC556735          DOI: 10.1002/j.1460-2075.1992.tb05325.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells.

Authors:  B E Pearson; H P Nasheuer; T S Wang
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Cellular targets for transformation by the adenovirus E1A proteins.

Authors:  P Whyte; N M Williamson; E Harlow
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

3.  The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor.

Authors:  N B La Thangue; B Thimmappaya; P W Rigby
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

4.  Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo.

Authors:  M C Blake; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

5.  The regulation of SV40 early gene expression in embryonal carcinoma stem cells--faithful transcriptional regulation in vitro.

Authors:  N B La Thangue; P W Rigby
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

6.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.

Authors:  K Buchkovich; L A Duffy; E Harlow
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

7.  Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF.

Authors:  G Draetta; F Luca; J Westendorf; L Brizuela; J Ruderman; D Beach
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B.

Authors:  J Pines; T Hunter
Journal:  Nature       Date:  1990-08-23       Impact factor: 49.962

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Cyclin A and the retinoblastoma gene product complex with a common transcription factor.

Authors:  L R Bandara; J P Adamczewski; T Hunt; N B La Thangue
Journal:  Nature       Date:  1991-07-18       Impact factor: 49.962

View more
  57 in total

1.  RRB1 and RRB2 encode maize retinoblastoma-related proteins that interact with a plant D-type cyclin and geminivirus replication protein.

Authors:  R A Ach; T Durfee; A B Miller; P Taranto; L Hanley-Bowdoin; P C Zambryski; W Gruissem
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300.

Authors:  J S Lee; R H See; T Deng; Y Shi
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

3.  Transcriptional repression and growth suppression by the p107 pocket protein.

Authors:  P Starostik; K N Chow; D C Dean
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen.

Authors:  N L Lill; M J Tevethia; R Eckner; D M Livingston; N Modjtahedi
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.

Authors:  A Hiraiwa; T Kiyono; S Suzuki; M Ohashi; M Ishibashi
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

6.  Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins.

Authors:  L Zhu; L Zhu; E Xie; L S Chang
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

7.  Transcriptional repression by the Rb-related protein p107.

Authors:  M Zamanian; N B La Thangue
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

8.  Cloning and characterization of mCtBP2, a co-repressor that associates with basic Krüppel-like factor and other mammalian transcriptional regulators.

Authors:  J Turner; M Crossley
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Oncogenic capacity of the E2F1 gene.

Authors:  D G Johnson; W D Cress; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 10.  The cell cycle and the retinoblastoma protein family.

Authors:  M E Ewen
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.